CTS Dallas and Phoenix Labs successfully implemented WNV NAT testing on the Panther Testing Platform on Monday, June 17th. As previously communicated, the Grifols assay and sample requirements are the same, and the package insert has been modified to state the assay is specific to the Panther Testing Platform. The new package insert, assay history list, and platform history list are now available on our website.
Reminder - Dr. Buff Mair is the new CTS Medical Director. Several of the CTS client forms specify li...
We are informing you that the FDA has announced their withdrawal of Guidance for ZIKV Testing. In th...
CTS Charlotte Lab successfully implemented WNV NAT testing on the Panther Testing Platform on Monday...
CTS successfully implemented Donor-Screen HLA® Class I and II testing on the Stratec Biomedical ...
A new Learning Center website will launch on Monday, March 30, 2020. While the link to the new Learn...
On May 9, 2019 the Food and Drug Administration issued a “Recommendations for Reducing the Ris...